Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease polycystic ovary syndrome
Phenotype C0023895|liver disease
Sentences 7
PubMedID- 25402369 Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis.
PubMedID- 25339805 Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome.
PubMedID- 25554608 Non-alcoholic fatty liver disease in women with polycystic ovary syndrome - clinical and metabolic aspects and lipoprotein lipase gene polymorphism.
PubMedID- 23980352 [effects of resolving method of chinese medicine on the lipid metabolism in polycystic ovary syndrome accompanied with non-alcoholic fatty liver disease].
PubMedID- 24246334 Obstructive sleep apnea predisposes to nonalcoholic fatty liver disease in patients with polycystic ovary syndrome.
PubMedID- 25136364 Cannabinoid receptor 1 gene polymorphisms and nonalcoholic fatty liver disease in women with polycystic ovary syndrome and in healthy controls.
PubMedID- 26039829 Prevalence of non-alcoholic fatty liver disease in women with polycystic ovary syndrome and its correlation with metabolic syndrome.

Page: 1